Eric Williams - Nov 8, 2024 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Co-Chief Operations Officer
Signature: /s/ Eric Williams
Stock symbol: USPH
Transactions as of: Nov 8, 2024
Transactions value $: -$191,680
Form type: 4
Date filed: 11/12/2024, 06:00 PM
Previous filing: May 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$192K	-2K	-11.89%	$95.84	14.8K	Nov 8, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported ($95.84)is weighted average price. The shares were sold in multiple transactions at prices ranging from $95.83 to $95.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 11,806 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,409 shares on January 1, 2025; 1,408 shares on April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates.

Content

The price reported ($95.84)is weighted average price. The shares were sold in multiple transactions at prices ranging from $95.83 to $95.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 11,806 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,409 shares on January 1, 2025; 1,408 shares on April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates.